NOX-A12 First-in-human (FIH) Study

NCT00976378 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Autologous Stem Cell Transplantation

Interventions

DRUG: NOX-A12
DRUG: NOX-A12

Sponsor

TME Pharma AG

Collaborators

[object Object]